Pacira Pharmaceuticals reported $48.81M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.64M 54K
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Amerisourcebergen ABC:US $ 1.22B 302.27M
Astellas Pharma 4503:JP 133.4B 3.71B
Biodelivery Sciences International BDSI:US $ 25.47M 311K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Cara Therapeutics CARA:US $ 5.88M 262K
Coherus Biosciences CHRS:US $ 39.92M 420K
Depomed DEPO:US $ 9.31M 16.92M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Horizon Pharma HZNP:US 360.26M 5.06M
Ironwood Pharmaceuticals IRWD:US $ 27.74M 690K
JAZZ PHA JAZZ:US 363.68M 65.35M
Johnson & Johnson JNJ:US $ 6B 73M
Lannett LCI:US $ 18.9M 2.67M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Omeros OMER:US $ 20.86M 699K
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Pfizer PFE:US $ 2.73B 61M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Supernus Pharmaceuticals SUPN:US $ 72.03M 2.5M
Teva Pharmaceutical TEVA:IT 864M 32M
Xeris Pharmaceuticals Inc XERS:US $ 24.24M 1.69M
Xoma XOMA:US $ 4.26M 328K
Zoetis ZTS:US $ 504M 9M